Johnson Fistel, PLLP is investigating Simulations Plus following the company's reduction of its 2025 revenue guidance from $90-93 million to $76-80 million, which led to a 24% stock decline. Further concerns arose after Simulations Plus reported a $67.3 million net loss including a $77.2 million non-cash impairment charge and dismissed its auditor Grant Thornton LLP amid unresolved accounting issues. These disclosures caused an additional 26% drop in shares. Investors who suffered losses are encouraged to contact Johnson Fistel for potential recovery options under federal securities laws.
Sandler, part of Trilliad, introduced the Sales Performance Ecosystem, the first platform to evaluate sales skills during actual buyer conversations using AI-powered coaching. This system links training directly to revenue by measuring real behavior ...
Pacira BioSciences awarded inducement grants to 10 new employees, including stock options for 9,200 shares and restricted stock units for 18,200 shares, as part of its Amended 2014 Inducement Plan. These awards, approved by the company's compensation...
Medallion Financial Corp., a specialty finance company, will announce its financial results for the quarter ending June 30, 2026, after market close on July 29, 2026. A conference call to discuss these results is scheduled for July 30 at 9:00 a.m. ET...
Quest Software has obtained FedRAMP High authorization for its Quest Identity Defense and Quest Identity Recovery products on Microsoft Azure Government, making it the only provider with a FedRAMP High SaaS offering for hybrid Active Directory and Mi...
MAIA Biotechnology announced positive initial efficacy data from its Phase 2 THIO-101 Part C trial for advanced non-small cell lung cancer (NSCLC), showing a 90.5% disease control rate in heavily pre-treated patients. The trial tests ateganosine foll...
